BFM
BLFS icon

Boothbay Fund Management’s BioLife Solutions BLFS Stock Holding History

Boothbay Fund Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,743
Closed -$153K – 751
2018
Q4 		$153K Buy
+12,743
New +$152K 0.02% 513

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Boothbay Fund Management's BLFS Position: Q1 2019 in Review

Boothbay Fund Management sold out of BioLife Solutions (BLFS) in Q1 2019, closing a stake of 12,743 shares — an estimated $153K sold.

Boothbay Fund Management first reported a position in BLFS in Q4 2018 and held it in 1 quarter. The position peaked at $153K in Q4 2018. 66 funds tracked by Wall St. Rank hold BLFS as of Q1 2019.

  • Boothbay Fund Management reported no remaining BioLife Solutions position as of Q1 2019 after selling out during the quarter.
  • Boothbay Fund Management sold 12,743 BioLife Solutions shares in Q1 2019, an estimated $153K.
  • Boothbay Fund Management first reported a position in BioLife Solutions in Q4 2018 and held it in 1 quarter.
  • Boothbay Fund Management's BioLife Solutions position peaked at $153K in Q4 2018.
  • 66 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2019.

Based on Boothbay Fund Management's 13F filing for Q1 2019, filed 15 May 2019.